APTEVO
They regard themselves as self-contained, owner-managed businesses with quick decision-making cycles. Their clients work in a variety of industries and are either SMEs or huge corporations. They work together to discover and implement solutions for everything from comprehensive IT infrastructure support to the very particular demands of larger IT departments. Companies in the business sector, state entities, and private and public schools are among their clients. They have mainly moved in the fo... llowing subject areas: continuous integration, continuous deployment, and continuous delivery infrastructure management according to DevOps principles, servers & virtualization, network, storage, client management & virtualization, internet connection & security, monitoring, automation & scripting, OS migrations, penetration testing, resiliency, Linux and open-source, in-house, cloud solutions, messaging.
APTEVO
Industry:
DevOps Internet Of Things IT Infrastructure Management Information Systems Small And Medium Businesses Software
Founded:
2011-01-01
Address:
Pratteln, Basel-Landschaft, Switzerland
Country:
Switzerland
Website Url:
http://www.aptevo.ch
Total Employee:
1+
Status:
Active
Contact:
+41 61 511 0855
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Apple Mobile Web Clips Icon Google Font API LetsEncrypt SSL By Default Font Awesome Mobile Non Scaleable Content
Similar Organizations
9apps
9apps is a provider of cloud based infrastructures and devops services.
ASPEX
ASPEX provides information technology services.
Automation Consultants
Automation Consultants is a consulting firm that offers devops, training, and cloud solutions.
Bitergo
Bitergo provides logistics software solutions and consulting services.
DAERO
DAERO provides software for businesses.
ICU IT
ICU IT provides information technology and services.
ISD Moldova
ISD is an extensive outsourcing provider that is committed to creating a consistent customer experience.
Stackmasters
Stackmasters provides cloud management and application hosting solutions for private, public and hybrid clouds.
Vtenext
Vtenext is a software development company that offers cloud-based CRM, open source CRM, add-ons, and plug-ins.
Official Site Inspections
http://www.aptevo.ch
- Host name: 212.243.197.119
- IP address: 212.243.197.119
- Location: Onex Switzerland
- Latitude: 46.1877
- Longitude: 6.0981
- Timezone: Europe/Zurich
- Postal: 1213
More informations about "Aptevo"
Aptevo - Crunchbase Company Profile & Funding
Where is Aptevo's headquarters? Aptevo is located in Pratteln, Basel-Landschaft, Switzerland. Who are Aptevo's competitors? Alternatives and possible …See details»
Aptevo Therapeutics | Clinical Stage Immuno-Oncology …
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel bispecific immunotherapies for the treatment of cancer. Aptevo is seeking to improve treatment outcomes and transform the lives of cancer …See details»
Willkommen bei Aptevo!
2011 gegründet, sehen wir uns als unabhängiges, inhabergeführtes KMU mit kurzen Entscheidungswegen. Unsere Kunden sind in diversen Branchen tätig, sind selber KMU oder auch Grossfirmen. Vom umfassenden IT …See details»
Robert G. Burrows Vice President, Investor Relations 240-631-3280 ...
“The selection of the board of directors for Aptevo Therapeutics is an important milestone as we advance towards completing our separation into two independent, publicly-traded companies,” …See details»
Aptevo AG in Pratteln - Kontakt und Auskünfte | Lixt
Aptevo AG in Pratteln | Aktiv | Gegründet 2011 | Management: Roger Dürrenberger, Jonas Waltisberg | Letzte Änderung: 21.12.2017See details»
Saol Therapeutics acquires three hyperimmune products from …
Under the terms of a purchase agreement executed by the companies, Saol Therapeutics will acquire the global rights to three hyperimmune products currently marketed by Aptevo: …See details»
Mission Statement, Vision, & Core Values (2025) of Aptevo …
Discover the Mission Statement, Vision, and Core Values of Aptevo Therapeutics in 2025. Gain insight into its strategic goals and community focus.See details»
APVO: Aptevo Therapeutics - Full Company Report - Zacks.com
Jul 22, 2024 Aptevo Therapeutics Inc. is a biotechnology company which focused on developing oncology and hematology therapeutics. The company's platform consists of ADAPTIR (TM).See details»
Aptevo AG in Staffelbach - Kontakt und Auskünfte | Lixt
Aptevo AG in Staffelbach | Aktiv | Gegründet 2017 | Management: | Letzte Änderung: 15.12.2017See details»
Aptevo Therapeutics Inc. - AnnualReports.co.uk
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapies for the treatment of cancer. The Company's lead clinical candidate, …See details»
Aptevo Therapeutics (APVO) Company Profile - Live Stock Chart, …
Aptevo Therapeutics (APVO) company profile, real-time stock chart, financial statistics, and comprehensive analysis. Get the latest Aptevo Therapeutics insights, financial statements, …See details»
Aptevo Therapeutics (APVO) - CapEdge
Get the latest news, data and filings for Aptevo Therapeutics (APVO), with free alerts. Includes transcripts, social sentiment, and more.See details»
Aptevo Therapeutics Announces Closing of $2.75 Million Offering
Jul 1, 2024 Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel immuno-oncology therapies for the treatment of cancer. Aptevo is seeking to …See details»
Aptevo Therapeutics Announces Exercise of Warrants for $6.2 …
Dec 12, 2024 Aptevo Therapeutics Inc. (Nasdaq: APVO) is a clinical-stage biotechnology company focused on developing novel bispecific immunotherapies for the treatment of cancer.See details»
Aptevo Therapeutics, Inc. (Aptevo Therapeutics, Inc.) - 药物管线_专 …
了解Aptevo Therapeutics, Inc. (Aptevo Therapeutics, Inc.)公司的药物管线，治疗领域，技术平台，以及它的11项临床试验, 92篇新闻和3篇文献，疾病领域:肿瘤，血液及淋巴系统疾病，技术 …See details»
Aptevo Therapeutics (NasdaqCM:APVO) Stock Forecast & Analyst ...
Discover Aptevo Therapeutics' earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers.See details»
Alligator Bioscience and Aptevo Therapeutics to Present Additional ...
Oct 29, 2024 Furthermore, Alligator is co-developing ALG.APV-527 with Aptevo Therapeutics Inc., several undisclosed molecules based on its proprietary technology platform, Neo-X …See details»
Aptevo's AML Drug Shows 90% Cancer Reduction in Early Trial …
Nov 20, 2024 Aptevo Therapeutics reports breakthrough results as first patient treated with mipletamig shows 90% reduction in leukemic blasts within 30 days in RAINIER AML trial.See details»
Aptevo Therapeutics Reports 3Q 2024 Financial Results and
Nov 7, 2024 There are several important factors that could cause Aptevo’s actual results to differ materially from those indicated by such forward-looking statements, including a deterioration in …See details»
Aptevo Therapeutics Engages Piper Sandler to Sell its RUXIENCE
Jun 25, 2020 SEATTLE, WA/ ACCESSWIRE/ July 21, 2020/ Aptevo Therapeutics Inc., a biotechnology company focused on developing novel immuno-oncology therapeutics based on …See details»